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Abstract 
Zingiber officinale Roscoe (red:ginger), one of the most widely consumed herbs in Asia, has been empirically used to treat various 
disorders in Indonesia. There are three known types of ginger: giant ginger or white ginger (Zingiber officinale var. Roscoe), small 
white ginger or ginger emprit (Zingiber officinale var. Amarum), and red ginger (Zingiber officinale var. Rubrum). The main components 
of ginger rhizome are carbohydrates, lipids, essential oils, terpenes, and phenol compounds such as gingerol (23-25%) and shogaol 
(18-25%). Many studies had confirmed beneficial effects of ginger against inflammation, free radicals, diabetes mellitus, bacterial 
infection, cancer, nausea, etc. Z. officinale var. Roscoe is considered a safe herbal with not significant adverse effects. This plant is 
potential to be developed for future phytomedicine, however further explorations on its clinical studies in humans is expected, 
especially the efficacy and safety of the risk of side effects.   
 
Introduction 
Zingiber officinale is one of the most widely 
used plants in Asia, Australia and many other 
countries.1,2,3,5,12 Empirically, Z. officinale has been used 
in digestive disorders (indigestion, flatulence, 
constpation, nausea), headache, rheumatism, cold and 
cough.6 
In the last few decades, Z. officinale is 
extensively studied for its medicinal properties by 
advanced scientific techniques and a variety of 
bioactive compounds had been isolated from different 
parts of the plant. The plant is reported for 
antimicrobial activity, anticancer activity, antioxidant 
activity, antidiabetic activity, nephroprotective activity, 
hepatoprotective activity, larvicidal activity, analgesic 
activity, anti-inflammatory activity and 
immunomodulatory activities.1,8,9,12,13 
More than seventy pharmacology studies of Z. 
officinale rhizomes have been reported. Most of the 
secondary metabolites of herbs are commercially 
important and find use in a number of pharmaceutical 
compounds. Flavonoids and phenolics are the most 
important groups of secondary metabolites and 
bioactive compounds in plants.9 Shogaol and gingerol 
are the most common bioactive compounds found in 
ginger, and have various pharmacological benefits.  
The present review is focused for the 
taxonomy, distribution, botanical description, 
secondary metabolite extraction, chemical 
constituents, pharmacological activity, side effect and 
toxicity of Z. officinale var Roscoe. 
 
 
Figure 1: Rhizome of Zingiber officinale var. Amarum 
(left), Zingiber officinale var. Roscoe (center), and 
Zingiber officinale var. Rubrum (right).33 
 
 
 
Taxonomy, Distribution, and Botanical Description  
Kingdom :  Plantae 
Division :  Magnoliophyta 
Class  :  Liliopsida 
Order :  Zingiberales  
Family :  Zingiberaceae 
Genus :  Zingiber  
Species :  Zingiber officinale var. Roscoe 8,34 
 
Ginger is a tropical plant, grows well in hot and 
humid climates. The plant is cultivated in China, Nepal, 
US, India, Bangladesh, Taiwan, Jamaica, Nigeria and 
Indonesia. India is the biggest producer of Z. officinale.8 
In Indonesia, Z. officinale is one of the export 
commodities, with the development area in 2010 
reaching 6,053 ha and the requirement of ginger seed is 
rhizome 12.106 tons/year. In accordance with the 
requirements of growing ginger, seed production sites 
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can be selected on land with climate type A, B, or C, with 
altitude of 300-900 dpl, average temperature 25-30oC, 
wet month number 7-9 months, rainfall 2,500-4,000 
mm/year, with light intensity 70-100%.14 
 
Ginger is herbaceous rhizomatous perennial, 
reaching up to 90 cm in height under cultivation. 
Rhizomes are aromatic, thick lobed, pale yellowish, 
bearing simple alternate distichous narrow oblong 
lanceolate leaves. The herb develops several lateral 
shoots in clumps, which begin to dry when the plant 
matures. Leaves are long and 2 - 3 cm broad with 
sheathing bases, the blade gradually tapering to a point. 
Inflorescence solitary, lateral radical pedunculate 
oblongcylindrical spikes. Flowers are rare, rather small, 
calyx superior, gamosepalous, three toothed; open 
splitting on one side, corolla of three sub equal oblong 
to lanceolate connate greenish segments.11 Stems 
erect. The leaves are often clear 2 rows with stem 
hugging, and tongue between the borders and leaf 
blades. Zygomorph flowers are bandaged. Petals forms 
as tube, with a tip hammered, often split in a midrib. 
Rhizome slightly flat, bagin tip short and flat branches, 
at each end of the branch there is a grooved curve 
inside. The outer pieces are yellowish brown, grooved 
lengthwise.15 
 
Extraction Method 
Secondary metabolite compounds are organic 
compounds derived from plants that have bioactive 
ability, for example phenolic, flavonid and terpenoid 
groups. A number of chemical and physical factors that 
could influence secondary metabolism in plant cell 
cultures have been found, including light, temperature, 
pH of medium, aeration, cell density, etc. Different light 
intensities are able to change synthesis of phenolics and 
flavonoids components in ginger.16,17 
The phenolic compounds represent one of the 
main groups of secondary metabolites in plants and 
they are present in foods and nutraceutics. These 
phytochemicals have a wide range of biological actions, 
including the ability to act as antioxidants, ameliorate 
inflammation, modulate enzyme activity, and regulate 
gene expression. The content of total polyphenolics in 
ginger extract was in amount of 181.41 mg/g ginger 
extract, and flavonoid in amount of 14.15 mg/g ginger 
extract.26 
Flavonoids are important in plant biochemistry 
and play an important role in plant physiology, acting as 
antioxidants, enzyme inhibitors, pigments and light 
screens.17 HPLC analysis revealed that the synthesis of 
flavonoids such as quercetin, catechin, epicatechin and 
naringenin were enhanced under low light intensity. A 
decreasing of light intensity also reduced the 
photosynthesis rate, and consequently diminished the 
soluble carbohydrate and plant biomass in Halia 
Bentong and Halia Bara. 17 
Drying of ginger rhizome should be done below 
70 0C for better quality dried products. For glycoside 
species, a maximum temperature of 100 0C is 
recommended, for mucilage species 65 0C and for 
essential-oil species 35 to 45 0C.19 
A study has been done to compare between 
decoct and maceration methods using water and 
ethanol as the solvent to extract flavonoid and phenolic 
contents. The ginger was oven-dried at 500C and 
macerated in ethanol (10 g in 100 ml) for 3 x 24 hours 
and 48 hours. The other sample was decocted in 
distilled water for 24 and 48 hours. Both of the solvents 
were rotavaporated.22 The ethanol extract is more 
active 20,22 than the others although its total flavonoid 
and phenols are lower. Water extract contains higher 
total flavonoid and phenols. 22 Traditionally, the 
extraction of 6-gingerol and 6-shogaol compounds is 
accomplished by reflux or Soxhlet extraction. However, 
prolonged extraction at high temperature may degrade 
the 6-gingerol and 6-shogaol compounds and involves 
high energy cost. In acidic media and under high 
extraction temperature 6-gingerol can be degraded to 
6-shogaol. The optimum extraction condition for all 
responses was at 76.9 °C for 3.4 h. Pharmaceutical 
quality of ginger could be improved significantly by 
optimizing of extraction process.28 
 
Chemical Constituent 
The most important compounds responsible 
for ginger’s therapeutic activities, are divided into non-
volatile and volatile compounds. The non-volatile 
fraction consists of an oleoresin. Elements responsible 
for gingers spicy flavor have been identified as the 
gingerols. The composition of the volatile fraction 
consists mainly of sesquiterpene derivatives, 
responsible for the aroma. Such compounds include (-)-
zingiberene, (+)-curcumene, (-)-β-sesquiphelandrene 
and β-bisabolene. The monoterpene derivatives are 
also a part of this essential oil.16,21 
Z. officinale rhizome contains 1–4% essential 
oil and oleoresin, but the chief constituent is 
sesquiterpene (53.57%).30 Several compounds have 
been identified in the essential oil, it’s estimated that 
there are 28 compounds. The most content were 
eudesmol (8.19%), γ-terpinene (7.88%), α-curcumene 
(7.28%),  zingiberene (6.06%), alloaromadendrene 
(6.56%), α-pinene (5.76%), δ-cadinene (3.84%), elemol 
(3.39%), farnesal (3.45%), E-β-farnesene (3.57%), neril 
acetate (2.8%) and β-myrcene (2.94%).32 
The main constituents of ginger are 
sesquiterpenoids with zingiberene as the main 
component. Other components include β- 
sesquiphellandrene, bisabolene and farnesene, which 
are sesquiterpenoids, and trace monoterpenoid 
fraction, (cineol, citral and β-sesquiphellandrene).20 
The gingerols is the primary active 
constituents, 5-hydroxy-1-(4-hydroxy-3-methoxy 
phenyl) decan-3-one is the most abundant in this 
constituent. Some other active compounds are mono 
and sesquiterpenes; camphene, betaphellandrene, 
curcumene, cineole, geranyl acetate, terphineol, 
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terpenes, borneol, geraniol, limonene, linalool, alpha-
zingiberene (30-70%), sesquiphellandrene (15-20%), 
betabisabolene (10-15%) and alpha-farmesene. Its Bulb 
is widely used because it contains gingerol, ethanol as 
active chemical compound. It also contains 
amadaldehyde, paradols, gingerdiols, gingerdiacetates, 
gingerdiones, 6-gingersulfonic acid, gingerenones.21 
 
Gingerol very unstable in the presence of heat 
and high temperatures will turn into shogaol. Shogaol 
which is spicier than gingerol, is the main component of 
dry ginger.22 Gingerols are thermally labile due to the 
presence of a b-hydroxy keto group in the structure and 
undergo dehydration readily to form the corresponding 
shogaols.31 Kinetics of [6]-gingerol degradation was 
characterized by least square fitting of a rate equation. 
It was found that gingerol exhibited novel reversible 
kinetics, in which it undergoes dehydration-hydration 
transformations with shogaol, the major degradation 
product. Degradation rates were found to be pH 
dependent with greatest stability observed at pH 4. The 
reversible degradation of [6]-gingerol at 100 0C and pH 
1 was relatively fast and reached equilibrium within 2 h. 
Rapid degradation of gingerol mainly occurs at high 
temperature and at an acidic pH, resulting in 
dehydration to form shogaol. Both gingerol and shogaol 
are most stable at pH 4 at 37 0C. 18 
The presence of a b-hydroxy keto functional 
group in the structure of gingerols is a key feature that 
makes them thermally labile and makes them undergo 
facile dehydration at high temperature and in acidic 
conditions. A kinetic study of the dehydration of [6]-
gingerol was carried out at 120 0C over a pH range from 
2.4 to 7.2. These studies showed that the dehydration 
of gingerol was pH and temperature dependent and 
followed first order kinetics. The mechanism of 
degradation of gingerol was considered in previous 
studies, including a retro-aldol reaction leading to 
formation of zingerone and aliphatic aldehydes, and 
dehydration to shogaol. Polymerization of shogaol was 
also demonstrated at higher temperature (1200C) in 12 
h.18 
In terms of lipophilic properties, [6]-shogaol is 
considerably more lipophilic than [6]-gingerol as a 
result of the loss of a hydroxyl group from gingerol on 
dehydration to shogaol. The difference in the 
lipophilicity would result in significant differences in 
bioavailability and pharmacokinetic parameters of 
these two compounds in vivo.18 
 
Pharmacology Activity  
The primary activities include 
antiinflammatory, antioxidant, analgesic effect, anti-
proliferative and hepatoprotective activity.21 
 
Antiinflammatory Activity 
First group to investigate the effect of ginger 
on platelet aggregation by using four ginger extracts, 
produced using different solvents (aqueous, n-hexane, 
chloroform, and ethyl acetate). They reported that 
ginger inhibited platelet aggregation using arachidonic 
acid (AA), epinephrine, adenosine diphosphate (ADP), 
and collagen as agonists. Others have corroborated this, 
reporting that certain ginger compounds inhibit in vitro 
platelet aggregation when using a variety of agonists 
(AA, collagen, platelet activating factor, and thrombin). 
This reduction in platelet aggregation was most potent 
when AA was used as the agonist, requiring lower 
concentrations to cause inhibition when compared to 
the other agonists. 24  
While few studies investigating the effect of 
ginger and its compounds on the clotting cascade have 
been undertaken, a considerable amount of in vitro 
research suggests that ginger compounds interact with 
AA-derived eicosanoid and thromboxane synthesis. The 
AA cascade can produce the eicosanoids involved in 
inflammation (i.e. prostaglandin E2) as well as 
thromboxane, which is amongst the many agonists of 
platelet aggregation. Numerous studies indicate that 
ginger extract and particular ginger compounds inhibit 
products specific to the cyclooxygenase pathway, 
including a reduction in thromboxane B2 (TxB2) 
production prostaglandin formation (PGF2a, PGE2, and 
PGD2), and cyclooxygenase enzyme activity. These 
same compounds also interact with the lipoxygenase 
pathway, including reductions in 5-lipoxygenase 
enzyme activity.24  
Finally, ginger compounds might also inhibit 
the activity of phospholipase A2, which suggests that 
ginger exerts its anti-platelet aggregating as well as its 
potential anti-inflammatory actions through interaction 
with one of the initial steps in this pathway. Due to the 
observed in vitro effects of ginger on the AA cascade, 
excessive bleeding and interactions with platelet 
therapy during cancer chemotherapy are of clinical 
concern. While the results of in vitro studies are 
consistent, these results are not always translatable to 
the complex human system. Due to the potential effects 
of ginger on platelet aggregation, ginger is a commonly-
cited example of an herbal supplement that should be 
avoided in patients with thrombocytopenia, platelet 
function defects or coagulopathy, such as populations 
using ginger for its antiemetic effect in cancer 
chemotherapy.24 
 
Antioxidant Activity 
Oxidation of biological molecules induces a 
variety of pathological disease including atherosclerosis 
or cancer. These damages are caused due to the 
presence of free radicals. [6]-gingerol, [6]-shogaol have 
displayed strong antioxidant activity in vitro. It is known 
that the antioxidant activity of plant extracts containing 
polyphenol components is due to their capacity to be 
donors of hydrogen atoms or electrons and to capture 
the free radicals. The ginger extract showed antioxidant 
effect in inhibiting DPPH radical, IC50 was 4.25 mg/ml. 
DPPH analysis is one of the tests used to prove the 
ability cof the components of the ginger extract to act 
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as donors of hydrogen atoms. DPPH radical does not 
react with flavonoids, which contain no OH-groups in B-
ring as well as with aromatic acids containing only one 
OH-group. 25 
 
Antidiabetic Activity 
A double-blind, placebo-controlled, 
randomized clinical trial was conducted on 20–60 year 
old patients with type 2 diabetes who did not receive 
insulin. Participants in the intervention and control 
groups were received 3 g of powdered ginger or placebo 
(lactose in capsules) daily for 3 months. This report 
shows that the 3 months supplementation of ginger 
improved glycemic indices, total antioxidant capacity 
(TAC) and paraoxonase-1 (PON-1) activity in patients 
with type 2 diabetes (T2DM). In this study, 3 g/day of 
ginger supplementation in T2DM patients for 3 months 
significantly decreased glucose, insulin, insulin 
resistance, highsensitive C-reactive protein (hs-CRP) 
and malate dehydrogenase (MDA) but significantly 
increased PON-1 and TAC compared to the control 
group. 27 
 
Antibacterial 
Ginger extract has showed antimicrobial 
activity against broad spectrum of pathogenic 
microorganisms such as Escherichia coli, Salmonella 
typhi, Bacillus subtilis and yeast Candida albicans. Main 
components, including [6]-gingerol and [12]-gingerol, 
isolated from ginger rhizome displayed antibacterial 
activity against periodontal bacteria. Hiserodt (1998) 
mentioned in his research that [10]-gingerol 
is active inhibitor of Mycobacterium avium and M. 
tuberculosis.25 Ethanolic extract of ginger is best 
effective against S. aureus when compared with E. 
feacalis.20 
 
Cytotoxic Activity 
Except for antioxidant and antimicrobial 
effects of phenolic compounds contained in Zingiber 
officinale, these components also have anti-
carcinogenic and 
anti-mutagenic activities. [6]-gingerol inhibits cell 
adhesion, invasion, motility and activities of human 
breast cancer cell lines.25 
 
Antinausea/Antiemetic 
The volatile oil of ginger known have 
antiemetic potency. The compounds as terpinolene, β-
pinene and α-phellandrene known had interact  with 5-
HT3 receptor channel system and antispasmodic effect 
at the rat ileum.35 
 
The Role of Gingerol and Shogaol in the Pharmacology 
Activity of Ginger 
Polyphenols are an important class of 
antioxidant defense.22 The metabolites of ginger have 
recognised as potent anti-oxidants due to their ability 
to inhibit the oxidation of various free radicals and the 
production of nitric oxide. The pharmacology activities 
of gingerol and shogaol are related with their possible 
mechanisms of action and structure–activity, as 
elucidated through selected in vitro and in vivo 
models.23 
 Gingerol and shogaol which show anticancer 
activity against a lot of cells, metabolism of ginger found 
mutagenic. Metabolites against various carcinomas and 
cell lines of lung, colon, skin, pancreas, prostate, liver, 
ovarian, colon, breast, kidney.23 
 [6]-gingerol is endowed with strong 
antioxidant activity both in vivo and in vitro, in addition 
to strong anti-inflammatory and antiapoptotic  
actions.16 [6]-Gingerol has been found to possess 
various pharmacological and physiological effects 
including analgesic, antipyretic, gastroprotective, 
cardiotonic, and antihepatotoxic activities. Gingerol 
also has a potent inhibitory effect on prostaglandin 
biosynthesis.18 The  [6]-gingerol is the most 
phytocompound potent  against cancer compared with 
the other ginger ligands like [8]-gingerol, [10]-gingerol 
and [6]-shogaol. The next research can be focused to 
develop 6-gingerol.31 
 
Side effect 
In generally Z. officinale is considered safe for 
use. There is a slight risk of toxicity in normal doses, but 
some people may have indigestion. Z. officinale can also 
cause contact dermatitis in sensitive individuals. Z. 
officinale reported to cause severe hyperkalemia in 
patients with cirrhosis. Use ginger with caution in 
people with liver disorders or liver disease who have 
been exposed before. 37 
 
Toxicity 
Acute toxicity studys with oral single dose of Z. 
officinale rhizome (2000 mg/Kg and 2500 mg/Kg) were 
observed for 14 day on rats, no death was found. LD50 > 
2000mg/Kg and LD50 > 2500mg/Kg.36  
Sub acute toxicity study with fine powder of Z. 
officinale rhizome (up to 2000 mg/kg/day) were 
administered orally to male and female rats for a 
duration 35 days showed no toxic effect. 36  
 
Dosage 
Ginger doses generally are 1-4 g per day, taken 
in divided doses.38 To prevent motion sickness: 0.5 g, 2–
4 times daily in adults and children more than 6 years 
and for dyspepsia: 2–4 g daily, as powdered plant 
material or extracts. 36, 37 
Conclusions 
Z. officinale var. rubrum is considered a safe herbal 
remedy with only slight and not significant adverse 
effects. This plant is potential to be developed for 
future phytomedicine, however it needs further 
explorations on its clinical studies in humans is 
expected, especially the efficacy and safety of the risk 
of side effects.   
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